34. Pathological and immunohistochemical prognostic factors in clinically node-negative breast cancer patients receiving adjuvant tamoxifen (BR3002 trial)

Saved in:
Bibliographic Details
Published in:Breast (Edinburgh) 1995-09, Vol.4 (3), p.237-237
Main Authors: Baker, P.R., Walker, R.A., Dunn, J.A., Parnell, S.M., Stonelake, P.S., Jevons, C.M., Gillespie, W.M., Baker, P.G., Dodson, L., Oates, G.D., Ellis, D.J., Lee, M.J.R., Morrison, J.M., Spooner, D.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0960-9776
1532-3080
DOI:10.1016/0960-9776(95)90126-4